Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Hinchcliffe, R.
1967.
An Attempt to Classify the Primary Vertigos.
The Journal of Laryngology & Otology,
Vol. 81,
Issue. 8,
p.
849.
Lange, G.
1968.
Isolierte medikament�se ausschaltung eines gleichgewichtsorgans beim morbus meni�re mit streptomycin-Ozothin�.
Archiv f�r Klinische und Experimentelle Ohren- Nasen- und Kehlkopfheilkunde,
Vol. 191,
Issue. 2,
p.
545.
Tsuiki, T.
and
Murai, S.
1971.
Familial incidence of streptomycin hearing loss and hereditary weakness of the cochlea.
International Journal of Audiology,
Vol. 10,
Issue. 5-6,
p.
315.
Bergsma, Daniel
1979.
Birth Defects Compendium.
p.
23.
Sugrue, D
Blake, S
Troy, P
and
MacDonald, D
1980.
Antibiotic prophylaxis against infective endocarditis after normal delivery--is it necessary?.
Heart,
Vol. 44,
Issue. 5,
p.
499.
WALBY, A. P.
and
KERR, A. G.
1982.
Streptomycin sulphate and deafness: a review of the literature.
Clinical Otolaryngology,
Vol. 7,
Issue. 1,
p.
63.
Pálfalvi, K. Rejtö L.
and
Komora, V.
1982.
Pure-Tone and Speech Intelligibility Disturbances in Patients with Ototoxic Disorders.
International Journal of Audiology,
Vol. 21,
Issue. 2,
p.
159.
Ohtani, Iwao
Ohtsuki, Kohsei
Aikawa, Tohru
Omata, Takeo
Ouchi, Jin
and
Saito, Takeo
1982.
Individual Variation and Mechanism of Kanamycin Ototoxicity in Rabbits.
Acta Oto-Laryngologica,
Vol. 94,
Issue. 1-6,
p.
413.
Viljoen, D L
Sellars, S L
and
Beighton, P
1983.
Familial aggregation of streptomycin ototoxicity: autosomal dominant inheritance?.
Journal of Medical Genetics,
Vol. 20,
Issue. 5,
p.
357.
HENRY, KENNETH R.
1983.
Development of Auditory and Vestibular Systems.
p.
273.
Lehnhardt, E.
1984.
Verhandlungsbericht 1984 der Deutschen Gesellschaft für Hals- Nasen- Ohren-Heilkunde, Kopf- und Hals-Chirurgie.
p.
58.
Hu, D N
Qui, W Q
Wu, B T
Fang, L Z
Zhou, F
Gu, Y P
Zhang, Q H
Yan, J H
Ding, Y Q
and
Wong, H
1991.
Genetic aspects of antibiotic induced deafness: mitochondrial inheritance..
Journal of Medical Genetics,
Vol. 28,
Issue. 2,
p.
79.
Tsuiki, Takashi
Murai, Kazuo
Kitamura, Ken
Murai, Seiko
and
Tamagawa, Yuya
1997.
Audiologic Features of Hearing Loss Due to the 1,555 Mutation of Mitochondrial DNA.
Annals of Otology, Rhinology & Laryngology,
Vol. 106,
Issue. 8,
p.
643.
Usami, Shin‐ichi
Abe, Satoko
Kasai, Miyo
Shinkawa, Hideichi
Moeller, Benjamin
Kenyon, Judy B.
and
Kimberling,, William J.
1997.
Genetic and Clinical Features of Sensorineural Hearing Loss Associated With the 1555 Mitochondrial Mutation.
The Laryngoscope,
Vol. 107,
Issue. 4,
p.
483.
Usami, Shin-Ichi
Abe, Satoko
Shinkawa, Hideichi
and
Kimberling, William J.
1998.
Sensorineural hearing loss caused by mitochondrial dna mutations.
Journal of Communication Disorders,
Vol. 31,
Issue. 5,
p.
423.
Wang, Shuchun
Bian, Qian
Liu, Zhiyuan
Feng, Yan
Lian, Nengjing
Chen, Hui
Hu, Changqin
Dong, Yuyun
and
Cai, Zhenghua
1999.
Capability of serum to convert streptomycin to cytotoxin in patients with aminoglycoside-induced hearing loss.
Hearing Research,
Vol. 137,
Issue. 1-2,
p.
1.
FISCHEL‐GHODSIAN, NATHAN
1999.
Genetic Factors in Aminoglycoside Toxicity.
Annals of the New York Academy of Sciences,
Vol. 884,
Issue. 1,
p.
99.
Fischel-Ghodsian, Nathan
1999.
Mitochondrial deafness mutations reviewed.
Human Mutation,
Vol. 13,
Issue. 4,
p.
261.
Fischel-Ghodsian, Nathan
2002.
Genetics of Auditory Disorders.
Vol. 14,
Issue. ,
p.
228.
Fischel-Ghodsian, Nathan
2005.
Genetic Factors in Aminoglycoside Toxicity.
Pharmacogenomics,
Vol. 6,
Issue. 1,
p.
27.